Investor type:

Investor style:

Database includes funds' biotherapeutics investments from Series A to IPO


Summary of funds

Fund Fund size ($M) Date closed Num. of portfolio IPOs since Jan-18 Num. of public company portfolio M&A since Jan-18 Value of IPO holdings at ($M) Proceeds from public company M&A at ($M) Total proceeds at ($M)

* Value of portfolio holdings is based on number of shares held at IPO


Investment preferences









Recent IPOs and M&A by fund


IPOs


Company name Ticker IPO date Amount raised in IPO ($M) IPO post-money ($M) Therapeutic areas Development stage Value of stake at IPO ($M) Value of stake at ($M)* Funds invested and value of stake / fund size

* based on shares held at IPO


M&A


Company name Acquiror name Deal date Upfront value ($M) Total value ($M) Therapeutic areas Development stage Est. amount invested Est. proceeds ($M)

Investment sizing, valuations and returns

Data not available for all investments


Company name Round name Date closed Latest market cap Total deal size Amount invested Post-money Percent of company acquired Therapeutic areas Stage Deal size / fund Investment in company / fund MOIC *

* based on shares held at IPO


List of recent investments


Company name Round Date Amount invested Therapeutic areas Stage Location Lead investors New non-lead investors Existing investors